CTI BioPharma
CTIC
#5622
Rank
NZ$2.07 B
Marketcap
NZ$15.73
Share price
0.00%
Change (1 day)
33.17%
Change (1 year)

CTI BioPharma (CTIC) - Cash on Hand

Cash on Hand as of March 2023 : NZ$0.10 Billion

According to CTI BioPharma 's latest financial reports the company has NZ$0.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

CTI BioPharma - Cash on Hand chart (from 1997 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$0.12 B31.41%
2021-12-31NZ$95.81 M31.81%
2020-12-31NZ$72.69 M45.42%
2019-12-31NZ$49.98 M-49.98%
2018-12-31NZ$99.94 M64.23%
2017-12-31NZ$60.85 M-4.2%
2016-12-31NZ$63.52 M-66.08%
2015-12-31NZ$0.18 B106.87%
2014-12-31NZ$90.53 M3.85%
2013-12-31NZ$87.17 M42.19%
2012-12-31NZ$61.31 M1.7%
2011-12-31NZ$60.28 M105.36%
2010-12-31NZ$29.35 M-43.61%
2009-12-31NZ$52.05 M183.11%
2008-12-31NZ$18.38 M-23.22%
2007-12-31NZ$23.95 M-68.66%
2006-12-31NZ$76.41 M-24.17%
2005-12-31NZ$0.10 B-37.94%
2004-12-31NZ$0.16 B15.26%
2003-12-31NZ$0.14 B-47.43%
2002-12-31NZ$0.26 B-56.52%
2001-12-31NZ$0.61 B76.33%
2000-12-31NZ$0.34 B664.35%
1999-12-31NZ$45.73 M447.76%
1998-12-31NZ$8.34 M-45.56%
1997-12-31NZ$15.33 M97.01%
1996-12-31NZ$7.78 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
NZ$16.34 B 15,905.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$28.56 B 27,864.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$5.07 B 4,864.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$2.98 B 2,824.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$17.16 B 16,699.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.81 B 3,633.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$16.88 B 16,427.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland